Pharmacokinetics in Toxicology Research

Similar documents
Constructing PK Models

IV solutions may be given either as a bolus dose or infused slowly through a vein into the plasma at a constant or zero-order rate.

1: CLINICAL PHARMACOKINETICS

PHAR 7633 Chapter 21 Non-Linear Pharmacokinetic Models

PHAR 7633 Chapter 19 Multi-Compartment Pharmacokinetic Models

Study (s) Degree Center Acad. Period Grado de Farmacia FACULTY OF PHARMACY 3 Annual PDG Farmacia-Nutrición Humana y Dietética

Statistics and Pharmacokinetics in Clinical Pharmacology Studies

Lecture 11 Enzymes: Kinetics

Nursing 113. Pharmacology Principles

How To Understand Enzyme Kinetics

Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV

Dynamic Process Modeling. Process Dynamics and Control

A Peak at PK An Introduction to Pharmacokinetics

QSAR. The following lecture has drawn many examples from the online lectures by H. Kubinyi

Pharmacology skills for drug discovery. Why is pharmacology important?

Lecture 3: Enzyme kinetics

DOSE-EFFECT RELATIONSHIP

PHAR 7633 Chapter 22 Non-Linear Regression Analysis of Pharmacokinetic Data Individual Data and Population Analysis

PRINCIPLES OF PHARMACOKINETICS

Absorption of Drugs. Transport of a drug from the GI tract

Biomedical Optics Theory

CLOSED LOOP MODEL FOR GLUCOSE INSULIN REGULATION SYSTEM USING LABVIEW

DIVISION OF HUMAN NUTRITION

( ) = ( ) = {,,, } β ( ), < 1 ( ) + ( ) = ( ) + ( )

BIOAVAILABILITY & BIOEQUIVALENCE TRIALS

Reaction Rates and Chemical Kinetics. Factors Affecting Reaction Rate [O 2. CHAPTER 13 Page 1

Chapter 12 - Chemical Kinetics

Fexinidazole a new oral treatment for sleeping sickness update of development

C.4 Applications of Differential Equations

Reaction of Blue Food Dye with Bleach

Exposure Modeling. Interpretation of biomonitoring data using physiologically based pharmacokinetic modeling. Centers for Human Health Assessment

Enzymes. Enzymes are characterized by: Specificity - highly specific for substrates

Chemical Kinetics. Reaction Rate: The change in the concentration of a reactant or a product with time (M/s). Reactant Products A B

SWAT INPUT DATA:.GW CHAPTER 24

Volume of Distribution

Exercise Day 3-13 A PBPK Model for Methyl Mercury

Basic Concepts of Pharmacokinetics

1. [20 pts] Find an integrating factor and solve the equation y 3y = e 2t. Then solve the initial value problem y 3y = e 2t, y(0) = 3.

Particle dissolution and solute absorption: Key factors in the pulmonary kinetics of inhaled drugs

L 2 : x = s + 1, y = s, z = 4s Suppose that C has coordinates (x, y, z). Then from the vector equality AC = BD, one has

How Long Does It Take a Person to Sober Up? Some Mathematics and Science of DUI

Determinants of Blood Oxygen Content Instructor s Guide

Teriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011).

Drug Excretion. Renal Drug Clearance. Drug Clearance and Half-Life. Glomerular Filtration II. Glomerular Filtration I. Drug Excretion and Clearance

Math Practice exam 2 - solutions

Review. Complex drug interactions; renal impairment; physiologically-based pharmacokinetic modeling (PBPK) Key words:

Biological importance of metabolites. Safety and efficacy aspects

GT-020 Phase 1 Clinical Trial: Results of Second Cohort

Deterministic and Stochastic Modeling of Insulin Sensitivity

Biokinetic model of americium in the beagle dog. Salt Lake City, UT (U.S.A.)

Equations for Primary FRCA

NONCLINICAL EVALUATION FOR ANTICANCER PHARMACEUTICALS

Diffusione e perfusione in risonanza magnetica. E. Pagani, M. Filippi

SAFETY PHARMACOLOGY STUDIES FOR HUMAN PHARMACEUTICALS S7A

The Rate and Extent of Calcium Bioavailability from Two Oral Dosage Forms in Rats

How To Remove A Drug By Therapeutic Apheresis

CHAPTER 13 Chemical Kinetics: Clearing the Air

ENZYMES - EXTRA QUESTIONS

Introduction. MassDEP, Office of Research and Standards 1 Tetrachloroethylene

Guidance for Industry

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version

The Kinetics of Atmospheric Ozone

Aging as a Risk Factor for Medication- Related Problems

Teacher s Guide. Chemicals & Human Health Website. Toxicology Activity

Section 4. Toxicology

PKPD modelling of the relationship between testosterone and PSA in patients with prostate cancer during treatment with leuprorelin

Unit I: Introduction To Scientific Processes

Uses of Derivative Spectroscopy

Public Assessment Report Scientific discussion. Tenofovir disoproxil Teva (tenofovir disoproxil) SE/H/1432/01/DC

KINETIC DETERMINATION OF SELENIUM BY VISIBLE SPECTROSCOPY (VERSION 1.8)

DIGESTION is the physical and

Modeling, Analysis, and Control of Dynamic Systems

DIVISION OF HUMAN NUTRITION

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25.

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5

Noncompartmental Analysis (NCA) in PK, PK-based Design

Medication Utilization. Understanding Potential Medication Problems of the Elderly

Clinical Study Synopsis for Public Disclosure

III. THE MICROBIAL BIOMASS

TRANSPORT OF BLOOD GASES From The Lungs To The Tissues & Back

CONTROL SYSTEM FOR INSULIN PUMPS IN THE MELLITUS DIABETES TREATMENTS

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

BSc in Medical Sciences with PHARMACOLOGY

Chemical Kinetics. 2. Using the kinetics of a given reaction a possible reaction mechanism

The Kinetics of Enzyme Reactions

Harmonization Project Document No. 2

PRINCIPLES OF PHARMACOLOGY. MEDICAL ASSISTANT S ROLE History: Drug Legislation & Regulation. Education: indication, instructions, side effects

Advisors: Masahiko Saito, Mathematics and Statistics Scott Campbell, Chemical & Biomedical Engineering. Problem Suggested By: Scott Campbell

Guidance for Industry

Math 231:Introduction to Ordinary Differential Equations Mini-Project: Modeling Chemical Reaction Mechanisms

Numerical Methods for Differential Equations

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

Insulin kinetics during HyperInsulinemia Euglycemia Therapy (HIET)

Self-Organization in Nonequilibrium Systems

Translate chemical symbols and the chemical formulas of common substances to show the component parts of the substances including:

Ethyl Glucuronide. Where is the Drug? Detection Windows. Urine. Blood. Absorption and Distribution. Metabolism. Excretion

Computing a BAC Estimate

Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development. Gerlie Gieser, Ph.D. Office of Clinical Pharmacology, Div. IV

Lab #11: Determination of a Chemical Equilibrium Constant

Transcription:

Pharmacokinetics in Toxicology Research Center for Human Health Assessment A Course on Physiologically Based Pharmacokinetic (PBPK) Modeling and Risk Assessment February 11 February 15, 2008 Copyright 2008 by The Hamner Institutes for Health Sciences. May not be reproduced without permission

External exposure Pharmacokinetics Absorbed dose Target dose Tissue interaction Early effect Pharmacodynamics Adverse effect Disease/injury

Pharmacokinetics Studies of the change in chemical distribution over time in the body Explores the quantitative relationship between Absorption, Distribution, Metabolism, and Excretion of a given chemical Classical models Data-based, empirical compartments Describes movement of chemicals with fitted rate constants Physiologically-based models: Compartments are based on real tissue volumes Mechanistically based description of chemical movement using tissue blood flow and simulated in vivo transport processes.

Example of Simple Kinetic Model: One-compartment model with bolus dose Dose Volume? Purpose: In a simple (1-compartment) system, determine volume of distribution Terminology: Compartment = a theoretical volume for chemical Steady-state = no net change of concentration Bolus dose = instantaneous input into compartment Method: 1. Dose: Add known amount (A) of chemical 2. Experiment: Measure concentration of chemical (C) in compartment 3. Calculate: A compartmental Volume (V)

Example of Simple Kinetic Model: One-compartment model with bolus dose Basic assumption: Well stirred, instant equal distribution within entire compartment Volume of distribution = A/C In this classical model, V is an operational volume V depends on site of measurement This simple calculation only works IF: Compound is rapidly and uniformly distributed The amount of chemical is known The concentration of the solution is known. What happens if the chemical is able to leave the container?

Describing the Rates of Chemical Processes - 1 Chemical in the System Rate equations: Describe movement of chemical between compartments The previous example had instantaneous dosing Now, we need to describe the rate of loss from the compartment Zero-order process: rate is constant, does not depend on chemical concentration rate = k x C 0 = k First-order process: rate is proportional to concentration of ONE chemical rate = k x C 1

Describing the Rates of Chemical Processes - 2 Chemical Systems Second-order process: rate is proportional to concentration of both chemicals Rate = k x C 1 x C 2 Saturable processes*: Rate is dependent on interaction of two chemicals One reactant, the enzyme, is constant Described using Michaelis-Menten* equation Rate = (V max x C) / ( C + K m ) 10 M-M kinetics *Michaelis-Menten kinetics can describe: Metabolism Carrier-mediated transport across membranes Excretion Rate 5 0 0 5 10 15 20 25 C

1-Comp model with bolus dose and 1 st order elimination Dose Conc? Concentration; Purpose: Examine how concentration changes with time Mass-balance equation (change in C over time): -da/dt=-k e x A, or -dc/dt=-k e x C where k e = elimination rate constant - Rearrange and integrate above rate equation C = C 0 x e -ke t, or ln C = ln C 0 -k e t Half-life (t 1/2 ): - to reduce concentration by 50% -replace C with C 0 /2 and solve for t t 1/2 = (ln 2)/k e = 0.693/k e

1-Comp model with bolus dose and 1 st order elimination Dose Conc Clearance: volume cleared per time unit - if k e = fraction of volume cleared per time unit, k e = CL/V (CL=ke ke*v) Calculating Clearance using Area Under the Curve (AUC): AUC = average concentration - integral of the concentration - C dt 10 CL = volume cleared over time (L/min) da/dt = - k e A = -k e V C da/dt = - CL C da = - CL C dt Dose = CL AUC CL = Dose / AUC 5 0 AUC 0 5 10 15 20 25

1-Comp model with continuous infusion and 1st order elimination Calculating Clearance at Steady State: At steady state, there is no net change in concentration: dc/dt = k 0 /V k e C = 0 Rearrange above equation: k 0 /V = k e C ss Steady State Since CL = k e V, CL = k 0 /C ss

2-Comp model with bolus dose and 1 st order elimination k 12 1 2 k 21 k e Calculating Rate of Change in Chemical: Central Compartment (C1): dc1/dt = k 21 C 2 - k 12 C 1 - k e C 1 Peripheral (Deep) Compartment (C2): dc2/dt = k 12 C 1 - k 21 C 2

Linear: Linear and Non-linear Kinetics All elimination and distribution kinetics are 1 st order Double dose double concentration 30 100 20 10 AUC 10 0 0 5 10 15 20 25 Non-linear: At least one process is NOT 1 st order Dose No direct proportionality between dose and compartment concentration 1 0 5 10 15 20 25 30 100 20 10 10 0 0 5 10 15 20 25 1 0 5 10 15 20 25

PBPK Models Building a PBPK Model: 1. Define model compartments Represent tissues 2. Write differential equation for each compartment 3. Assign parameter values to compartments Compartments have defined volumes, blood flows 4. Solve equations for concentration Numerical integration software (e.g. Berkeley Madonna, ACSL) Venous side Chemical in air Lungs Other Fat tissues Liver Elimination Simple model for inhalation Arterial side

PBPK Model Compartment Types - Storage compartment Chemical in air QT CVT QT CA Same as 1-compartment model with continuous infusion Lungs Other Fat tissues Liver Rate in = Q T C A where Q T = tissue blood flow, C A = arterial blood conc Elimination Rate out = Q T C VT = Q T C T /P T where C VT = conc in tissue blood, C T = conc in tissue, P T = partition coefficient Assume Well-stirred compartment, so that, C VT = C T /P T

PBPK Model Compartment Types - Storage compartment Chemical in air QT CVT QT CA Same as 1-compartment model with continuous infusion Lungs Other Fat tissues Liver Calculating Change in Amount: Change in amount = rate in rate out E lim ination da/dt = Q T x (C A C T /P T ) dc/dt = Q T x (C A C T /P T ) /V C A Dose C VT